Antibodies against β1 and β2 adrenergic receptors in myasthenia gravis

Journal of Neuroimmunology

Volumn 91, Issue 1-2, 1998, Pages 82-88

  Xu, Bi Ying ^a   Pirskanen, Ritva ^b   Kari Lefvert, Ann ^a  

^a Center for Molecular Medicine   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

adrenergic receptor; Antibody; Myasthenia gravis

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; AUTOANTIBODY; BETA ADRENERGIC RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; DRUG RECEPTOR BINDING; EXCITATION CONTRACTION COUPLING; HEART DILATATION; HEART DISEASE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILE FORCE; HUMAN; HUMAN CELL; MYASTHENIA GRAVIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; AGED; AMINO ACID SEQUENCE; CHEMISTRY; CYTOLOGY; EPITOPE MAPPING; GENETICS; HEART MUSCLE; IMMUNOLOGY; MOLECULAR GENETICS; MUSCLE CELL; SKELETAL MUSCLE;

AGED; AMINO ACID SEQUENCE; AUTOANTIBODIES; EPITOPE MAPPING; HEART DISEASES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MOLECULAR SEQUENCE DATA; MUSCLE FIBERS; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; MYOCARDIUM; RECEPTORS, ADRENERGIC, BETA;

EID: 0032476753     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00159-3     Document Type: Article

References (25)

1. Aarli J.A., Stefansson K., Marton L.S.G., Wollmann R.L. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin. Exp. Immunol. 82:1990;284-288.
2. Bertolini J.N., Benson E.M. The role of human interleukin-6 in B-cell isotype regulation and differentiation. Cell. Immunol. 125:1990;197-209.
3. +) B cells to secrete IgG1 and IgG3. J. Exp. Med. 179:1994;757-762.
4. Buyuközturk K., Özdemir C., Kohen D. Electrocardiographic findings in 24 patients with myasthenia gravis. Acta Cardiol. 31:1976;301-305.
5. Eng H., Magnusson Y., Matell G., Lefvert A.K., Saponja R., Hoebeke J. β2-adrenergic receptor antibodies in myasthenia gravis. J. Autoimmun. 5:1992;213-227.
6. Fujieda S., Zhang K., Saxon A. IL-4 plus CD40 monoclonal antibody induces human B cell γ subclass-specific isotype switch: switching to γ1, γ3, and γ4, but not γ2. J. Immunol. 155:1995;2318-2328.
7. Genkins, G., Mendelow, H., Sobel, H.J., Osserman, K.E., 1961. Myasthenia gravis: analysis of thirty-one consecutive post-mortem examinations. In: Viets (Ed.), Myasthenia Gravis. The 2nd International Symposium Proceedings. C.C. Thomas, Springfield, pp. 519-530.
8. Gilbert E.M., Olsen S.L., Renlund D.G., Bristow M.R. Beta-adrenergic receptor regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am. J. Cardiol. 71:1993;23C-29C.
9. Hofstad H., Ohm O.-J., Mork S.J., Aarli J.A. Heart disease in myasthenia gravis. Acta Neurol. Scand. 70:1984;176-184.
10. Insel P.A., Hammond H.K. β-adrenergic receptors in heart failure. J. Clin. Invest. 92:1993;2564.
11. Kawano Y., Noma T. Role of interleukin-2 and interferon-gamma in inducing production of IgG subclasses in lymphocytes of human newborns. Immunology. 88:1996;40-48.
12. Kawano Y., Takeshi N., Yata J. Regulation of human IgG subclass production by cytokines IFN-γ and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J. Immunol. 153:1994;4948-4958.
13. Kawano Y., Noma T., Kou K., Yoshizawa I., Yata J. Regulation of human IgG subclass production by cytokines: human subclass production enhanced diffentially by interleukin-6. Immunology. 84:1995;278-284.
14. Lundgren M., Persson U., Larsson P., Magnusson C., Edvard Smith C.I., Hammarström L., Severinson E. Interleukin 4 induces synthesis of IgE and IgG 4 in human B cells. Eur. J. Immunol. 19:1989;1311.
15. Magnusson Y., Höyer S., Lengagne R., Chapot M.-P., Guillet J.-G., Hjalmarson Å., Strosberg A.D., Hoebeke J. Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin. Exp. Immunol. 78:1989;42-48.
16. Magnusson Y., Marullo S., Höyer S., Waagstein F., Andersson B., Vahine A., Guillet J.-G., Strosberg A.D., Hjalmarson Å., Hoebeke J. Mapping of a functional autoimmune epitope on the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 86:1990;1658-1663.
17. Magnusson Y., Wallukat G., Guillet J.-G., Hjalmarson Å., Hoebeke J. Functional analysis of rabbit anti-peptide antibodies which mimic autoantibodies against the β1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J. Autoimmun. 4:1991;893-905.
18. Mendelow H., Genkins G. Studies in myasthenia gravis: cardiac and associated pathology. J. Mt. Sinai Hosp. 21:1954;218-225.
19. Mygland Å., Tysnes O.-B., Matre R., Aarli J.A., Gilhus N.E. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis. Autoimmun. 17:1994;327-331.
20. Ohta M., Ohta K., Itoh N., Kurobe M., Hayashi K., Nishitani H. Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: identification of anti-myosin, actin, and α-actinin antibodies by a solid-phase radioimmunoassay and a Western blotting analysis. Clin. Chim. Acta. 187:1990;255-264.
21. Oosterhuis H.H.G.H. Studies in myasthenia gravis. Part 1. A clinical study of 180 patients. J. Neurol. Sci. 1:1964;512-546.
22. Punnonen J., Aversa G.G., Cocks B.G., McKenzie A.N.J., Menon S., Zurawski G., de Waal Malefyt R., de Vries J.E. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc. Natl. Acad. Sci. U.S.A. 90:1993;3730-3734.
23. Willians C.L., Lennon V.A. Thymic B-lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, α-actinin or actin. J. Exp. Med. 164:1986;1043-1059.
24. Xu B.Y., Yi Q., Pirskanen R., Matell G., Eng H., Lefvert A.K. Decreased β2-adrenergic receptor density on peripheral blood mononuclear cells in myasthenia gravis. J. Autoimmun. 10:1997;401-406.
25. Yi Q., He W., Matell G., Pirskanen R., Magnusson Y., Eng H., Lefvert A.K. T and B lymphocytes reacting with the extracellular loop of the β2-adrenergic receptor (β2AR) are present in the peripheral blood of patients with myasthenia gravis. Clin. Exp. Immunol. 103:1996;133-140.